Aranthan Jones II, Chief Corporate Affairs Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 45,972 shares at $20.01 ($920K) on 2021-02-24, disclosed to the SEC on 2021-02-26.
Open-market sale of $920k VNDA by Chief Corporate Affairs Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.01 | 22,986 | $460K | 50.0% |
| 2 | $20.01 | 22,986 | $460K | 50.0% |
| Total | $20.01 avg | 45,972 | $920K | 100% |
| Filing → |
| VNDA | SELL | 2021-03-16 | $319K | — | Filing → |
| VNDA | SELL | 2021-03-03 | $139K | — | Filing → |
| VNDA | SELL | 2020-08-14 | $85K | — | Filing → |